QF
WHWK

QVT Financial’s Whitehawk Therapeutics WHWK Stock Holding History

QVT Financial’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.9M Hold
4,615,709
– – 1.17% 15
2025
Q4 		$10.6M Hold
4,615,709
– – 0.91% 20
2025
Q3 		$8.33M Hold
4,615,709
– – 0.59% 21
2025
Q2 		$8.2M Buy
4,615,709
+100,000
+2% +$174K 0.73% 25
2025
Q1 		$7.64M Buy
4,515,709
+2,202,007
+95% +$5.75M 0.7% 21
2024
Q4 		$7.3M Buy
+2,313,702
New +$5.24M 0.65% 18

Other funds holding WHWK

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

QVT Financial's WHWK Position: Q1 2026 in Review

QVT Financial held its Whitehawk Therapeutics (WHWK) position steady in Q1 2026 at 4,615,709 shares worth $15.9M. The position accounts for 1.17% of the portfolio, ranked #15.

QVT Financial first reported a position in WHWK in Q4 2024 and has held it in 6 quarters since. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • QVT Financial held 4,615,709 shares of Whitehawk Therapeutics worth $15.9M as of Q1 2026.
  • QVT Financial left its Whitehawk Therapeutics share count unchanged in Q1 2026.
  • Whitehawk Therapeutics made up 1.17% of QVT Financial's portfolio in Q1 2026, its #15 holding.
  • QVT Financial first reported a position in Whitehawk Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on QVT Financial's 13F filing for Q1 2026, filed 15 May 2026.